Microchip Technology Inc (MCHP)
Official siteTECHNOLOGY • SEMICONDUCTORS • NASDAQ
Market Cap: $33.57B
Last updated: Nov 17, 2026 at 11:06 AM ET
Microchip Technology Inc (MCHP) Financials: Revenue, Profit and Cash Flow
Microchip Technology reported revenue of $4.71B for the fiscal year ended Mar 31, 2026, up 7.1% from the year before. That year, net income was $230.00M with a net margin of 4.9%, operating cash flow was $962.10M and free cash flow was $760.20M. The quarter ended Sep 30, 2026 had revenue of $1.62B and net income of $401.40M.
Revenue and Margins
The operating margin was 10.4% in the fiscal year ended Mar 2026. Over the 9 years to Mar 2026, revenue grew from $3.41B, a compound annual rate of 3.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Mar 2026 | $4.71B | +7.1% | 57.7% | 10.4% | 4.9% |
| Mar 2025 | $4.40B | -42.3% | 56.1% | 6.7% | 0.0% |
| Mar 2024 | $7.63B | -9.5% | 65.4% | 33.7% | 25.0% |
| Mar 2023 | $8.44B | +23.7% | 67.5% | 36.9% | 26.5% |
| Mar 2022 | $6.82B | +25.4% | 65.2% | 27.1% | 18.8% |
| Mar 2021 | $5.44B | +3.1% | 62.1% | 18.4% | 6.4% |
| Mar 2020 | $5.27B | -1.4% | 61.5% | 12.3% | 10.8% |
| Mar 2019 | $5.35B | +34.4% | 54.8% | 13.4% | 6.7% |
| Mar 2018 | $3.98B | +16.8% | 60.8% | 23.5% | 6.4% |
| Mar 2017 | $3.41B | N/A | 51.6% | 8.1% | 4.8% |
Income Statement
In the fiscal year ended Mar 2026, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 862.6% from the same quarter a year earlier.
Annual
| Line item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.71B | $4.40B | $7.63B | $8.44B | $6.82B | $5.44B | $5.27B | $5.35B | $3.98B | $3.41B |
| Cost of revenue | $1.99B | $1.93B | $2.64B | $2.74B | $2.37B | $2.06B | $2.03B | $2.42B | $1.56B | $1.65B |
| Gross profit | $2.72B | $2.47B | $5.00B | $5.70B | $4.45B | $3.38B | $3.24B | $2.93B | $2.42B | $1.76B |
| Research and development | $1.09B | $983.80M | $1.10B | $1.12B | $989.10M | $836.40M | $877.80M | $826.30M | $529.30M | $545.30M |
| Operating income | $490.10M | $296.30M | $2.57B | $3.12B | $1.85B | $998.10M | $647.10M | $714.30M | $936.30M | $275.80M |
| Net income | $230.00M | -$500.00K | $1.91B | $2.24B | $1.29B | $349.40M | $570.60M | $355.90M | $255.40M | $164.60M |
| EBITDA | $1.21B | $1.11B | $3.49B | $4.13B | $3.05B | $2.24B | $2.00B | $1.72B | $1.66B | $806.90M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.62B | $1.48B | $1.31B | $1.19B | $1.14B | $1.08B | $970.50M | $1.03B | $1.16B | $1.24B | $1.33B | $1.77B |
| Gross profit | $1.07B | $938.90M | $799.60M | $706.90M | $637.90M | $576.70M | $501.10M | $561.40M | $668.50M | $736.90M | $789.90M | $1.12B |
| Operating income | $464.50M | $336.80M | $217.40M | $151.70M | $88.90M | $32.10M | -$100.30M | $30.90M | $146.60M | $219.10M | $253.50M | $529.40M |
| Net income | $401.40M | $229.80M | $144.20M | $62.70M | $41.70M | -$18.60M | -$154.60M | -$53.60M | $78.40M | $129.30M | $154.70M | $419.20M |
Balance Sheet
As of Mar 2026, total debt of $5.54B exceeded cash and equivalents by $5.29B.
Annual
| Line item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.37B | $15.37B | $15.87B | $16.37B | $16.20B | $16.48B | $17.43B | $18.35B | $8.26B | $7.69B |
| Current assets | $2.38B | $2.99B | $3.01B | $3.07B | $2.45B | $2.15B | $2.22B | $2.21B | $3.36B | $2.31B |
| Cash and equivalents | $240.30M | $771.70M | $319.70M | $234.00M | $317.40M | $280.00M | $401.00M | $428.60M | $901.30M | $908.70M |
| Total liabilities | $7.94B | $8.30B | $9.22B | $9.86B | $10.30B | $11.14B | $11.84B | $13.06B | $4.98B | $4.42B |
| Short-term debt | $38.80M | $35.70M | $999.40M | $1.40B | $0 | $1.32B | $608.80M | $1.36B | $1.31B | $50.00M |
| Long-term debt | $5.50B | $5.63B | $5.00B | $5.04B | $7.69B | $7.58B | $8.87B | $8.95B | $1.76B | $2.90B |
| Shareholder equity | $6.43B | $7.08B | $6.66B | $6.51B | $5.89B | $5.34B | $5.59B | $5.29B | $3.28B | $3.27B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.66B | $14.41B | $14.37B | $14.33B | $14.47B | $14.98B | $15.37B | $15.63B | $15.62B | $15.84B | $15.87B | $16.14B |
| Total liabilities | $8.02B | $7.96B | $7.93B | $7.77B | $7.77B | $8.12B | $8.30B | $9.60B | $9.35B | $9.43B | $9.22B | $9.06B |
| Cash and equivalents | $457.00M | $272.30M | $240.30M | $250.70M | $236.80M | $566.50M | $771.70M | $586.00M | $286.10M | $315.10M | $319.70M | $281.00M |
| Shareholder equity | $6.64B | $6.45B | $6.43B | $6.56B | $6.70B | $6.86B | $7.08B | $6.03B | $6.28B | $6.41B | $6.66B | $7.08B |
Cash Flow
In the fiscal year ended Mar 2026, free cash flow was 79.0% of operating cash flow. Dividends came to 143.4% of it, with no share repurchases.
Annual
| Line item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $962.10M | $898.10M | $2.89B | $3.62B | $2.84B | $1.92B | $1.54B | $1.67B | $1.42B | $1.06B |
| Capital expenditures | $201.90M | $290.60M | $398.50M | $600.40M | $491.80M | $181.60M | $139.10M | $247.50M | $213.90M | $85.50M |
| Free cash flow | $760.20M | $607.50M | $2.49B | $3.02B | $2.35B | $1.73B | $1.40B | $1.43B | $1.21B | $974.00M |
| Dividends paid | $1.09B | $975.70M | $911.50M | $695.30M | $503.80M | $388.30M | $350.10M | $344.40M | $337.50M | $315.40M |
| Share repurchases | $0 | $96.50M | $982.10M | $945.80M | $425.60M | $0 | $0 | N/A | N/A | N/A |
| Investing cash flow | -$195.50M | -$287.80M | -$392.10M | -$599.50M | -$477.70M | -$173.30M | -$133.20M | -$6.81B | -$1.01B | -$2.84B |
| Financing cash flow | -$1.30B | -$158.30M | -$2.41B | -$3.10B | -$2.33B | -$1.86B | -$1.44B | $4.66B | -$415.30M | $595.50M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $419.20M | $511.50M | $257.00M | $341.40M | $88.10M | $275.60M | $205.90M | $271.50M | $43.60M | $377.10M | $430.00M | $853.30M |
| Capital expenditures | $99.60M | $52.10M | $52.10M | $44.50M | $63.60M | $41.70M | $56.30M | $42.10M | $66.60M | $125.60M | $76.10M | $87.30M |
| Free cash flow | $319.60M | $459.40M | $204.90M | $296.90M | $24.50M | $233.90M | $149.60M | $229.40M | -$23.00M | $251.50M | $353.90M | $766.00M |
Frequently Asked Questions About MCHP
What is Microchip Technology's annual revenue?
Microchip Technology reported revenue of $4.71B for the fiscal year ended Mar 31, 2026.
How fast is Microchip Technology's revenue growing?
Revenue was up 7.1% for the fiscal year ended Mar 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was -17.6%.
Is Microchip Technology profitable?
Yes. Microchip Technology reported net income of $230.00M for the fiscal year ended Mar 31, 2026, with a net margin of 4.9%.
How much free cash flow does MCHP generate?
For the fiscal year ended Mar 31, 2026, operating cash flow of $962.10M minus capital expenditures of $201.90M produced free cash flow of $760.20M.
How much debt does Microchip Technology have?
The balance sheet dated Mar 31, 2026 reported long-term debt of $5.50B, short-term debt of $38.80M and cash and equivalents of $240.30M.
MCHP pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts